Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. (Q45377066)
Jump to navigation
Jump to search
scientific article published on 13 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. |
scientific article published on 13 February 2009 |
Statements
Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction (English)
Myrielle Mathieu
Jozef Bartunek
Bachar El Oumeiri
Karim Touihri
Ielham Hadad
Philippe Thoma
Agnes Mendes da Costa
Maryam Mahmoudabady
Dominique Egrise
Didier Blocklet
Naïma Mazouz
Robert Naeije
13 February 2009